Efficacy and clinical observation of Shenling Baizhu Pill in treating irritable bowel syndrome

Abstract

Objective To observe the clinic efficacy of Shenling Baizhu Pill on patients with irritable bowel syndrome(IBS). Methods Ninety patients with IBS were collected and divided into Chinese patent medicine group and western medicine group by random number method,45 patients in each group,the Chinese patent medicine group received Shenling Baizhu pill group treatment,the western medicine group was gave Smectite Powder treatment.The changes of clinical symptoms,intestinal tract microorganism and serum inflammatory factor of patients were observed and compared between two groups before and after treatment.The clinical symptoms was evaluated by questionnaire,the Lactobacillus,Bifidobacterium,enterobacteria and yeast were determined by cultivation,the levels of IL-10,IL-18 and TNF-αwere detected by enzyme linked immunosorbent assay (ELISA). Results Two groups before treatment of anaerobic bacteria in feces reduction,aerobic bacteria increased serum IL-18 and TNF-alpha content,increased,the content of IL-10 decreased.Shenling Baizhu Pill intervention for 8 weeks in patients with intestinal anaerobic bacteria[(B/E 1.07±0.49)]and serum IL-10 [(43.65±9.52)mg/L]content increased,aerobic bacteria[(B/E 1.07±0.49)],IL-18[(82.06±21.07)mg/L] and TNF-alpha[(28.44±10.20)mg/L]decreased.The IL-18 decreased the most,was different with the western medicine group,there was a statistical significance(t=9.926,P<0.01).Two groups had no bad reaction. Conclusion Shenling Baizhu Pill can effectively regulates and improves the intestinal micro-environment,promote the growth of intestinal probiotics and remodeling the intestinal function of biological barrier, decrease the levels of proinflammatory factors and rise the anti-inflammatory factors level,which has a good clinic effect in treating IBS. Key words: Shenling Baizhu Pill; Irritable bowel syndrome; Intestinal microecology